Skip links
Companies
› Japan › Oncotherapy Science Co., Ltd.
Company registry profile
Oncotherapy Science Co., Ltd. logo

Oncotherapy Science Co., Ltd.

Active

From the registry

Registration details

Registration No.
1020001077150
Incorporation Date
2015-10-05
Company Type
Not disclosed
Address
Kawasaki Ward, Kawasaki City, Japan
Website
www.oncotherapy.co.jp/
Status
Active
Country
Japan
Source: National Tax Agency — Corporate Number Publication SiteRegistry coverage
Registry summary

Company overview

Oncotherapy Science Co., Ltd. is a registered legal entity registered in Japan under 1020001077150, and its current status with National Tax Agency — Corporate Number Publication Site is active. The company was incorporated on 5 October 2015 and lists its registered address as Kawasaki Ward, Kawasaki City, Japan. 2 shareholders are on record for Oncotherapy Science Co., Ltd., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn.

Data Provenance
This record is sourced directly from official government registries, including National Tax Agency — Corporate Number Publication Site.

View data sources →

We don’t stop at registry data.
Every company record is enriched with additional intelligence:
  • Company fundamentals
  • Corporate linkage & group structures
  • Digitized company financials
  • Firmographics — websites, social profiles, revenue and employee estimates

View full data dictionary →

Shareholders

2

Swipe or scroll for more columns

Shareholder Type Holding Source Document
SPDR Portfolio Developed World ex-US ETF 75.8% National Tax Agency — Corporate Number Publication Site

Registry notes and limitations

Two shareholders are currently on record for Oncotherapy Science Co., Ltd., reflecting the kabunushi meibo (shareholder register) maintained under Articles 121-122 of the Companies Act rather than a public filing.

The largest of these is SPDR Portfolio Developed World ex-US ETF, holding 75.8% — a majority holding — followed by SPDR (R) Idx Shares-SPDR (R) S&P (R) International Small Cap ETF at 24.2%.

Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Officers

3

HK
Hatsuo Kato ACTIVE

Residence
🇯🇵 Japan
Occupation
Executive Chairman

JS
Junichi Shimada ACTIVE

Residence
🇯🇵 Japan
Occupation
President, Ceo & Director

JP
Jae-hyun Park ACTIVE

Residence
🇯🇵 Japan
Occupation
Chief Scientific Officer & Director

Registry notes and limitations

Three officers are currently on record for Oncotherapy Science Co., Ltd., filed with National Tax Agency — Corporate Number Publication Site. Hatsuo Kato serves as Executive Chairman; Junichi Shimada serves as President, Ceo & Director; Jae-hyun Park serves as Chief Scientific Officer & Director.

Management authority at Oncotherapy Science Co., Ltd. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.

Group Structure

Top of recorded group
Oncotherapy Science Co., Ltd.
Japan
CANCER PRECISION MEDICINE, K.K.
JapanJP 2020001122509

How these relationships were recorded

Oncotherapy Science Co., Ltd. has no recorded parent company — it sits at the top of its own group structure, with 1 subsidiary recorded beneath it across 1 jurisdiction. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.

Those 1 subsidiary spans Japan jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.

Registry questions

Frequently asked questions

Who owns Oncotherapy Science Co., Ltd.?

Two shareholders are currently on record for Oncotherapy Science Co., Ltd., reflecting the kabunushi meibo (shareholder register) maintained under Articles 121-122 of the Companies Act rather than a public filing. The largest of these is SPDR Portfolio Developed World ex-US ETF, holding 75.8% — a majority holding — followed by SPDR (R) Idx Shares-SPDR (R) S&P (R) International Small Cap ETF at 24.2%. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Who is Oncotherapy Science Co., Ltd.'s UBO (Ultimate Beneficial Owner)?

Every shareholder recorded for Oncotherapy Science Co., Ltd. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.

How many shareholders does Oncotherapy Science Co., Ltd. have on record?

2 shareholders are shown on record for Oncotherapy Science Co., Ltd..

What is Oncotherapy Science Co., Ltd.'s company registration number?

Oncotherapy Science Co., Ltd.'s registration number is 1020001077150, filed with National Tax Agency — Corporate Number Publication Site in Japan. Its current status on the register is active.

Is Oncotherapy Science Co., Ltd. still an active company?

Oncotherapy Science Co., Ltd.'s status on National Tax Agency — Corporate Number Publication Site is listed as active.

When was Oncotherapy Science Co., Ltd. incorporated?

Oncotherapy Science Co., Ltd. was incorporated on 5 October 2015, according to National Tax Agency — Corporate Number Publication Site.

What is Oncotherapy Science Co., Ltd.'s registered address?

The registered address on file for Oncotherapy Science Co., Ltd. is Kawasaki Ward, Kawasaki City, Japan.

Who are the officers/directors of Oncotherapy Science Co., Ltd.?

Three officers are currently on record for Oncotherapy Science Co., Ltd., filed with National Tax Agency — Corporate Number Publication Site. Hatsuo Kato serves as Executive Chairman; Junichi Shimada serves as President, Ceo & Director; Jae-hyun Park serves as Chief Scientific Officer & Director. Management authority at Oncotherapy Science Co., Ltd. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

Does Oncotherapy Science Co., Ltd. have a parent company or subsidiaries?

Oncotherapy Science Co., Ltd. has no recorded parent company — it sits at the top of its own group structure, with 1 subsidiary recorded beneath it across 1 jurisdiction. Those 1 subsidiary spans Japan jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.

Other companies in Japan

All companies in Japan

This website uses cookies to improve your web experience.